| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/05/2011 | US20110105483 Triazole compounds that modulate hsp90 activity |
| 05/05/2011 | US20110105456 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 05/05/2011 | US20110105447 Novel modulators of calcium release-activated calcium channel |
| 05/05/2011 | US20110105440 HEXAHYDROCYCLOPENTYL[f]INDAZOLE SULFONAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 05/05/2011 | US20110105427 Deazapurines and uses thereof |
| 05/05/2011 | US20110105424 Glucopyranoside compound |
| 05/05/2011 | US20110105418 Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof |
| 05/05/2011 | US20110104308 Treatment For Diseases Relying On Discovery That Thioredoxin Mediates Nitric Oxide |
| 05/05/2011 | US20110104277 Oxygen barrier film coatings for pharmaceutical dosage forms |
| 05/05/2011 | US20110104217 Bioactive Peptides and Method of Using Same |
| 05/05/2011 | US20110104184 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 05/05/2011 | US20110104146 Antithrombotic agents and methods of use thereof |
| 05/05/2011 | US20110104140 Use of non-catalytic form of heparanase and peptides thereof for reversing the anti-coagulant effects of heparinoids |
| 05/05/2011 | US20110104128 Device and Method for Transfecting Cells for Therapeutic Use |
| 05/05/2011 | US20110104114 Polysaccharide-Protein Conjugates Reversibly Coupled Via Imine Bonds |
| 05/05/2011 | US20110104052 Methods of synthesis and use of chemospheres |
| 05/04/2011 | EP2316944A2 Binding agents: chimeric ligand/receptor proteins |
| 05/04/2011 | EP2316919A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316918A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316858A1 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (NAIT) |
| 05/04/2011 | EP2316455A1 Pharmaceutical compositions for treating cancer |
| 05/04/2011 | EP2315593A1 Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
| 05/04/2011 | EP1855661B1 Formulation for aviptadil |
| 05/04/2011 | EP1807095B1 2-o, 3-o desulfated heparin for the treatment of heparin-induced thrombocytopenia (hit) syndrome |
| 05/04/2011 | EP1581560B1 Anti-idiotypic antibodies against factor viii inhibitor and uses thereof |
| 05/04/2011 | EP1465666B1 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy |
| 05/04/2011 | EP1294746B1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 05/04/2011 | CN201814829U Back roller massage device capable of being refilled with essential oil perfume |
| 05/04/2011 | CN1847229B 2,4,8- trisubstituted-8H- pyridine[2,3-d] pyridine -7-one compound |
| 05/04/2011 | CN102046618A Hydroxyquinoxalinecarboxamide derivative |
| 05/04/2011 | CN102046205A Factor IX conjugates with extended half-lives |
| 05/04/2011 | CN102046006A Improved quenching methods for red blood cell pathogen inactivation |
| 05/04/2011 | CN102041224A Prepared yellow pine healthcare wine |
| 05/04/2011 | CN102041223A Chrysanthemum prepared medicinal wine |
| 05/04/2011 | CN102041222A Medicinal liquor prepared from schisandra berry |
| 05/04/2011 | CN102041210A Prepared medicinal wine with hair blackening and beautifying effects |
| 05/04/2011 | CN102040667A Method for biologically removing protein from sea cucumber polysaccharide |
| 05/04/2011 | CN102040652A Solid-liquid phase combined Eptifibatide synthesis method |
| 05/04/2011 | CN102040550A Inhibitors of cytosolic phospholipase A2 |
| 05/04/2011 | CN102040535A Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate |
| 05/04/2011 | CN102040517A Resveratrol derivative and application thereof to medicament |
| 05/04/2011 | CN102040516A Resveratrol derivative and medical application thereof |
| 05/04/2011 | CN102038955A Method for preparing anticoagulant polysulfones material by fourier reaction grafting |
| 05/04/2011 | CN102038936A Application of SIRT1 (silent mating type information regulation-1) in preparing upregulation globin gene expression and preparing medicine for curing anemia |
| 05/04/2011 | CN102038887A Formula of functional proteome for quickly supplementing human albumin and preparation method thereof |
| 05/04/2011 | CN102038861A Chinese medicinal preparation for treating aplastic anemia |
| 05/04/2011 | CN102038779A Quality control method of quatre pill as traditional Chinese medical preparation |
| 05/04/2011 | CN102038728A Quality control method for erigeron breviscapus (Vant.) hand-mazz. |
| 05/04/2011 | CN102038727A Method for preparing purified alkaloid part in Chinese angelica-szechuan lovage rhizome supercritical CO2 extract |
| 05/04/2011 | CN102038726A Method for preparing organic acid part purified from angelica sinensis-ligusticum wallichii supercritical CO2 extractive |
| 05/04/2011 | CN102038718A Fructificatio Lasiosphaerae seu Calvatiae combined drug and applications thereof |
| 05/04/2011 | CN102038713A Method of producing a dry earthworm powder |
| 05/04/2011 | CN102038694A Syringin pharmaceutical composition and preparation method and application thereof |
| 05/04/2011 | CN102038693A Medicament for inhibiting thrombus formation |
| 05/04/2011 | CN102038692A Medical composition with antiplatelet condensation activity |
| 05/04/2011 | CN102038648A Powder injection for treating peptic ulcers and preparation method thereof |
| 05/04/2011 | CN102038647A Preparation method for coenzyme A freeze-dried powder injection |
| 05/04/2011 | CN102038642A Ginkgolide B solid dispersoid and preparation method thereof |
| 05/04/2011 | CN102038639A Alprostadil injection preparation |
| 05/04/2011 | CN102038638A Clindamycin hydrochloride injection and preparation method thereof |
| 05/04/2011 | CN101690754B Medicine for curing cerebral thrombosis sequela |
| 05/04/2011 | CN101579354B Application of chitosan in preparing drugs for preventing and curing bacterial septicemia of silkworm |
| 05/04/2011 | CN101530427B Pharmaceutical composition for promoting hematopoiesis and preparation method thereof |
| 05/04/2011 | CN101491608B Medicine of effective fractions of compounded prescription of Huomai Tiaozhi capsule and preparation technology thereof |
| 05/04/2011 | CN101422456B Preparation method and quality detection method for medicine composition drop-pills |
| 05/04/2011 | CN101402641B Oxime derivatives containing thienopyridine, preparation method and application thereof |
| 05/04/2011 | CN101333223B Method for preparing clopidogrel and salts thereof |
| 05/04/2011 | CN101284838B Ethylene imine derivates with thienopyridine, preparation method and applications thereof |
| 05/04/2011 | CN101214289B Chinese medicinal composition for treating thrombocytopenic purpura and preparation thereof |
| 05/03/2011 | US7935692 Polyamine compounds are used to mobilize and harvest CD34+ cells via apheresis with and without combinations with other mobilizing factors; bind to chemokine receptors; regeneration of heart tissue |
| 05/03/2011 | CA2484340C 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 05/03/2011 | CA2467517C Substituted benzoxazoles and analogues as estrogenic agents |
| 05/03/2011 | CA2456507C Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods, especially for use as a plasma volume expander |
| 05/03/2011 | CA2443632C Timed pulse release composition |
| 05/03/2011 | CA2440438C Heterocyclic compounds |
| 05/03/2011 | CA2425933C Combination of catechin and quercetin for pharmaceutical or dietary use |
| 05/03/2011 | CA2174961C Desferrioxamine oral delivery system |
| 04/28/2011 | WO2011050262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/28/2011 | WO2011049213A1 Fused heterocyclic compound and thrombopoietin receptor activator |
| 04/28/2011 | WO2011049127A1 5-hydroxypyrimidine-4-carboxamide derivative having hydrocarbon ring group |
| 04/28/2011 | WO2011049126A1 5-hydroxypyrimidine-4-carboxamide derivative |
| 04/28/2011 | WO2011048350A1 Treatment using reprogrammed mature adult cells |
| 04/28/2011 | WO2011048253A1 Multipotent nestin-positive cells |
| 04/28/2011 | WO2011048097A1 Bismuth-containing composition for reducing the phosphate concentration in fluids |
| 04/28/2011 | WO2011047770A2 Pyrazolopyrimidine derivatives |
| 04/28/2011 | WO2011047518A1 Enteral nutrition comprising marine bioactive polysaccharide, preparation method and use thereof |
| 04/28/2011 | WO2008017586A3 Special carbonyl-bis imino compounds for using as p2y11 receptor agonists in the treatment of immune diseases |
| 04/28/2011 | US20110098345 Aptamers to Tissue Factor Pathway Inhibitor and Their Use as Bleeding Disorder Therapeutics |
| 04/28/2011 | US20110098324 Prolyl hydroxylase inhibitors |
| 04/28/2011 | US20110098319 Fatty acid derivatives for oral administration endowed with high palatability |
| 04/28/2011 | US20110098250 Water-soluble benzoazepine compound and its pharmaceutical composition |
| 04/28/2011 | US20110098247 Substituted Dihydroquinazolines as Platelet ADP Receptor Inhibitors |
| 04/28/2011 | US20110097388 Methods of Expressing Proteins with Disulfide Bridges |
| 04/28/2011 | US20110097375 Formulation for preventing or reducing bleeding at a surgical site |
| 04/28/2011 | US20110097301 Angiogenesis promoted by caged growth factors |
| 04/28/2011 | DE102009043260A1 Pyridinyl-imidazolonderivate Pyridinyl-imidazolone derivatives |
| 04/28/2011 | CA2781522A1 Treatment using reprogrammed mature adult cells |
| 04/28/2011 | CA2780533A1 5-hydroxypyrimidine-4-carboxamide derivative |
| 04/28/2011 | CA2777881A1 Pyrazolopyrimidine derivatives |
| 04/27/2011 | EP2314673A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |